| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |